INCYTE CORP
INCYTE CORP
Aktie · US45337C1027 · INCY · 896133 (XNAS)
Übersicht Finanzkennzahlen
68,77 USD
3,41 % 2,27 USD
NASDAQ (XNAS) · Aktuelle Kurse und Charts bei MoneyPeak
06.06.2025 20:00

Aktuelle Kurse von INCYTE CORP

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
INCY
USD
06.06.2025 20:00
68,77 USD
67,24 USD
+2,28 %
XLON: London
London
0J9P.L
USD
06.06.2025 15:05
67,97 USD
67,24 USD
+1,09 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % 5,70 % 15,37 % -1,88 % -9,42 % 16,44 % -26,46 %

Firmenprofil zu INCYTE CORP Aktie

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. Its clinical stage products include ruxolitinib, a steroid-refractory chronic graft-versus-host-diseases (GVHD); itacitinib, which is in Phase II/III clinical trial to treat naïve chronic GVHD; and pemigatinib for treating bladder cancer, cholangiocarcinoma, myeloproliferative syndrome, and tumor agnostic. In addition, the company engages in developing Parsaclisib, which is in Phase II clinical trial for follicular lymphoma, marginal zone lymphoma, and mantel cell lymphoma. Additionally, it develops Retifanlimab that is in Phase II clinical trials for MSI-high endometrial cancer, merkel cell carcinoma, and anal cancer, as well as in Phase II clinical trials for patients with non-small cell lung cancer. It has collaboration agreements with Novartis International Pharmaceutical Ltd.; Eli Lilly and Company; Agenus Inc.; Calithera Biosciences, Inc; MacroGenics, Inc.; Merus N.V.; Syros Pharmaceuticals, Inc.; Innovent Biologics, Inc.; Zai Lab Limited; Cellenkos, Inc.; and Nimble Therapeutics, as well as clinical collaborations with MorphoSys AG and Xencor, Inc. to investigate the combination of tafasitamab, plamotamab, and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma, and relapsed or refractory follicular lymphoma. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware.

Investierte Fonds

Folgende Fonds haben in investiert: INCYTE CORP investiert:

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in Mio
562,22
Anteil (%)
1,32 %
Fonds
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. in Mio
659,98
Anteil (%)
0,18 %
Fonds
iShares Edge MSCI World Minimum Volatility UCITS ETF USD (Dist)
Vol. in Mio
3,86
Anteil (%)
0,14 %
Fonds
iShares Edge MSCI World Minimum Volatility UCITS ETF EUR Hedged (Acc)
Vol. in Mio
147,77
Anteil (%)
0,14 %
Fonds
iShares Nasdaq 100 UCITS ETF EUR Hedged (Acc)
Vol. in Mio
214,38
Anteil (%)
0,12 %

Unternehmensdaten

Name INCYTE CORP
Firma Incyte Corporation
Symbol INCY
Website https://www.incyte.com
Heimatbörse XNAS NASDAQ
WKN 896133
ISIN US45337C1027
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Pharmaceuticals
CEO Mr. Herve Hoppenot
Marktkapitalisierung 11 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 2,6 T
Adresse 1801 Augustine Cut-Off, 19803 Wilmington
IPO Datum 2018-01-29

Aktien-Splits

Datum Split
01.09.2000 2:1
10.11.1997 2:1

Ticker Symbole

Name Symbol
Frankfurt ICY.F
London 0J9P.L
NASDAQ INCY

Weitere Aktien

Investoren die INCYTE CORP die halten, haben auch folgende Aktien im Depot:
AMGEN INC
AMGEN INC Aktie
AUTODESK INC
AUTODESK INC Aktie
BIOGEN INC
BIOGEN INC Aktie
CISCO SYSTEMS INC
CISCO SYSTEMS INC Aktie
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Aktie
FIDELITY MSCI UTILITIES INDEX ETF
FIDELITY MSCI UTILITIES INDEX ETF ETF
GLOBAL FASHION GRP EO-,01
GLOBAL FASHION GRP EO-,01 Aktie
ILLUMINA INC
ILLUMINA INC Aktie
INTEL CORP
INTEL CORP Aktie
iShares Trust iShares iBonds Oct 2025 Term TIPS ETF
iShares Trust iShares iBonds Oct 2025 Term TIPS ETF Fonds
MICROSOFT CORP
MICROSOFT CORP Aktie
UNDER ARMOUR A DL-,000333
UNDER ARMOUR A DL-,000333 Aktie
VERTEX PHARMACEUTICALS INC
VERTEX PHARMACEUTICALS INC Aktie
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025